TY - JOUR
AU - Page, Michael M
AU - Watts, Gerald F
TI - PCSK9 inhibitors – mechanisms of action
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2016
ET - 2016/10/01
VL - 39
IS - 5
SP - 164
EP - 167
DO - 10.18773/austprescr.2016.060
LA - eng
UR - https://australianprescriber.tg.org.au/articles/pcsk9-inhibitors-mechanisms-of-action.html
KW - familial hypercholesterolaemia
KW - LDL cholesterol
KW - proprotein convertase subtilisin/kexin type 9
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -